The weekly litigation news digest is live. Subscribe now

IP Verse

Methods For Sequencing Of Cell Free Polynucleotides - EP3882362

The patent EP3882362 was granted to Guardant Health on May 8, 2024. The application was filed on Mar 15, 2014 under application number EP21157571A. The patent is currently recorded with a legal status of "Revoked".

EP3882362

GUARDANT HEALTH
Application Number
EP21157571A
Filing Date
Mar 15, 2014
Status
Revoked
Aug 29, 2025
Publication Date
May 8, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
STRAWMANFeb 10, 2025FINNEGAN EUROPEADMISSIBLE
MARGARET DIXONFeb 7, 2025MEWBURN ELLISADMISSIBLE

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2001053519
DESCRIPTIONUS2003152490
DESCRIPTIONUS2011160078
DESCRIPTIONUS6582908
DESCRIPTIONUS7537897
OPPOSITIONUS2012071331
OPPOSITIONUS7741463
OPPOSITIONWO2004081183
OPPOSITIONWO2010127186
OPPOSITIONWO2012042374
OPPOSITIONWO2012142213
OPPOSITIONWO2012148477
OPPOSITIONWO2013123442
OPPOSITIONWO2013138510
OPPOSITIONWO2013142389
SEARCHUS2009325239
SEARCHUS8209130
SEARCHWO2008154317

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents